Clinical trial
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
NCT00441129 · Medtronic Diabetes, Industry · Completed
Key facts
| NCT number | NCT00441129 |
|---|---|
| Title | Obtain a Good Blood Glucose Control With the Paradigm Real Time System |
| Official title | To Assess Whether Type 1 Diabetic Patients Treated With M D I and in Poor Metabolic Control Can Improve Using the Paradigm® Real Time System Compared to Self-Monitoring Blood Glucose and Continuous Subcutaneous Insulin Infusion |
| Acronym | RTD |
| Lead sponsor | Medtronic Diabetes, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Device |
| Interventions | Minimed paradigm Real Time Sytem, Minimed Paradigm 512/712 Insulin pump |
| Enrollment | 115 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Feb 28, 2007 |
| Last update posted | Dec 5, 2018 |
| Countries | France |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: